They also suggest that the novel α7 nAChR negative allosteric modulator BNC210 at the 300 mg dose has potential as an anti-anxiety medication, perhaps because it restores the homoeostatic balance between glutamatergic and GABAergic systems. This evidence concerns the gene CHRNA7 and Anxiety.